New Key Statistics Module, Z-Score and F-Score
NYSE:HQL Key Ratios
Market Cap $ M | 348.55 |
Enterprise Value $ M | 348.55 |
P/E(ttm) | 16.47 |
PE Ratio without NRI | 16.47 |
Forward PE Ratio | -- |
Price/Book | 0.87 |
Price/Sales | 13.99 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 1.62 |
Revenue (TTM) $ M | 23.00 |
EPS (TTM) $ | 0.79 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -- |
EV-to-EBITDA | -- |
PEG | -- |
Shares Outstanding M | 26.79 |
Net Margin (%) | 95.02 |
Operating Margin % | -- |
Pre-tax Margin (%) | 95.02 |
Quick Ratio | -- |
Current Ratio | -- |
ROA % (ttm) | 5.36 |
ROE % (ttm) | 5.49 |
ROIC % (ttm) | -- |
Dividend Yield % | 10.22 |
Altman Z-Score | -- |
Piotroski F-Score | 5.00 |
Positive ROA | Y |
Positive CFROA | N |
Higher ROA y-y | Y |
Cash flow > Earnings | N |
Lower Leverage y-y | Y |
Higher Current Ratio y-y | Y |
Less Shares Outstanding y-y | N |
Gross Margin Increase y-y | N |
Higher Asset Turnover y-y | Y |
HQL Number of Guru Trades
HQL Volume of Guru Trades
Gurus Latest Trades with NYSE:HQL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:HQL is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
abrdn Life Sciences Investors Insider Transactions
No Available Data
News about NYSE:HQL
Total 0- 1